Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 70INDUSTRY 64NETWORK 4OTHER_GOV 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 4Recurrence 2Vomiting 1Neoplasms, Plasma Cell 1Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Hypersensitivity 1Disease Progression 1

Interventions

Surgical Procedures, Operative 2Dexamethasone 2temoporfin 1pomalidomide 1pembrolizumab 1nimotuzumab 1liposomal doxorubicin 1ledipasvir 1ibrutinib 1golimumab 1Vinorelbine 1Tomography, X-Ray Computed 1Thalidomide 1Sofosbuvir 1Rituximab 1Ribavirin 1Radiotherapy 1Radiation 1Paclitaxel 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Mitoxantrone 1Mastectomy 1Irinotecan 1Infliximab 1Immunotherapy, Adoptive 1Hematologic Tests 1Drug Therapy 1Docetaxel 1Diagnostic Imaging 1Dermoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Recurrence × Dexamethasone × Clear all
NCT02733380 2020-04-01

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Unknown
20 enrolled
Lymphoid

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03601624 2018-11-14

MM-POM-2018

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

Phase 2 Unknown
18 enrolled
Plasma cell

Multiple Myeloma, Recurrence, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡